FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35914911000001104: Tazarotene 0.05% gel (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110965701000001119 Tazarotene 0.05% gel (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110965801000001111 Tazarotene 0.05% gel en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tazarotene 0.05% gel Has NHS dm+d (dictionary of medicines and devices) dose form indicator Continuous dose form indicator true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route gel.cutaneous ontology form and route true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Topical route false Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Cutaneous true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Is a Tazarotene true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Is a Product containing tazarotene false Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has active ingredient Tazarotene false Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has specific active ingredient Tazarotene true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tazarotene 0.05% gel 60 gram Has VMP True Tazarotene 0.05% gel Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel 30 gram Has VMP True Tazarotene 0.05% gel Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc) Is a True Tazarotene 0.05% gel Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) Is a True Tazarotene 0.05% gel Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start